Across the recent three months, 7 analysts have shared their insights on Chemours (NYSE:CC), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 1 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 1 | 1 | 2 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $24.57, a high estimate of $30.00, and a low estimate of $18.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.58%.
Investigating Analyst Ratings: An Elaborate Study
An in-depth...
Login or create a forever free account to read this news
Sign up/Log in
